General Surgery

General Surgery

General Surgery ACS NSQIP Outcomes

January 1, 2022 – December 31, 2022

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall general surgery ACS NSQIP performance benchmarked against 701 participating sites.

General Surgery (701 Sites)NObservedExpected
30 Day Mortality12871.48%2.00%
30 Day Morbidity128716.16%17.03%
Cardiac 12871.09%1.18%
Unplanned Intubation12851.63%1.40%
Ventilator > 48 Hours12811.95%1.75%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus12872.87%2.39%
Renal Failureᵃ12843.50%2.42%
Urinary Tract Infection (UTI)12871.01%1.66%
Surgical Site Infection (SSI)12778.93%9.59%
C.diff Colitisᵃ12871.55%0.72%
Unplanned Reoperation12874.82%5.21%
Unplanned Readmissionᵃ128713.44%11.39%

American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.